A urine test for a rare and elusive disease

Proteins found in urine may enable diagnosis of Kawasaki disease

2012-12-20

(Press-News.org) Boston, Mass.—A set of proteins detected in urine by researchers at Boston Children's Hospital may prove to be the first biomarkers for Kawasaki disease, an uncommon but increasingly prevalent disease which causes inflammation of blood vessels that can lead to enlarged coronary arteries and even heart attacks in some children. If validated in more patients with Kawasaki disease, the markers could make the disease easier to diagnose and give doctors an opportunity to start treatment earlier.

The discovery was reported online by a team led by members of the Proteomics Center and the departments of Pathology and Rheumatology at Boston Children's on Dec. 20 in the journal EMBO Molecular Medicine.

While only about two in 10,000 children in the United States develop Kawasaki disease annually, the disease is on the rise both here and worldwide; in Japan the prevalence approaches one in 100 among children under the age of 5. No one knows what triggers the disease, and though it can occur at any age, it most often appears in children under 5.

Kawasaki disease is highly treatable—approximately 80 percent of children diagnosed with it require only one round of treatment—but making a diagnosis is often a significant challenge. And if it is not detected early, Kawasaki disease can have serious consequences: About 25 percent of children with untreated Kawasaki disease develop coronary artery aneurysms.

"The symptoms of Kawasaki disease, including fever, rash and enlarged lymph nodes, mimic those found in many common viral or bacterial infections in children," said Susan Kim, MD, MMSc, a rheumatologist with the Kawasaki Disease Program at Boston Children's. "The process of diagnosis includes considering a long list of possibilities. Especially in children with an incomplete presentation, a diagnosis of Kawasaki can be delayed or even missed.

"We'd like to have a test that we can use to proactively distinguish children with Kawasaki disease from those with other causes of fever," she continued. "This would allow us to start treatment much earlier and greatly reduce the risks of long-term complications."

In order to develop an effective diagnostic test, Kim worked with proteomics experts Alex Kentsis, MD, PhD, and Hanno Steen, PhD, to screen the protein content of urine from patients with Kawasaki disease using mass spectrometry and enzyme-linked immunosorbant assays. Kentsis and Steen had previously identified urine biomarkers for acute appendicitis, an effort aimed at reducing the numbers of children who either underwent unnecessary appendectomies or who had a ruptured appendix that did not show up on an imaging scan.

The team identified 190 proteins found only in the urine of children with Kawasaki disease. When validated in samples from 107 children seen at Boston Children's with suspected Kawasaki disease (53 of whom were ultimately diagnosed with it), two of the proteins—filamin C and meprin A, which are associated with injury to blood vessel and cardiac muscle cells as well as inflammation—proved to be 98 percent accurate at distinguishing children with Kawasaki disease from ones with conditions mimicking the disease. Levels of the markers also closely tracked treatment response and, in one patient, disease recurrence.

Other Kawasaki-associated markers detected in the study included proteins involved in immune activation, immune regulation and pathogen recognition.

The researchers caution that for the moment the markers are still research tools and that they are working to refine and validate the findings in a larger group of patients. "We are working with the hospital's Technology Innovation and Development Office to find corporate partners with which to develop a clinical-grade test," said Steen, who directs the Proteomics Center.

"This is very exciting and our results are very promising," said Kim. "Of course we need to validate the results in a broader cohort of patients, ideally in collaboration with other centers. We are hopeful that these findings will help us to develop a test that can help specifically and proactively detect or rule out Kawasaki in suspected patients in the future."

### The study was supported by Harvard Catalyst | The Harvard Clinical and Translational Science Center (NIH grant UL1RR025758), the National Heart, Lung and Blood Institute (grants U01HL068285, U01HL068270, U01HL068269, U01HL068292, U01HL068290, U01HL068288, U01HL068281 and U01HL068279), the National Center for Research Resources (grant M01RR02172), the National Cancer Institute (grant K08CA160660) and Boston Children's Hospital's Division of Immunology and Translational Research Program.

Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's also is a teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org/. END

ELSE PRESS RELEASES FROM THIS DATE:

First ever 'atlas' of T cells in human body

2012-12-20

New York, NY (December 20, 2012) — By analyzing tissues harvested from organ donors, Columbia University Medical Center (CUMC) researchers have created the first ever "atlas" of immune cells in the human body. Their results provide a unique view of the distribution and function of T lymphocytes in healthy individuals. In addition, the findings represent a major step toward development of new strategies for creating vaccines and immunotherapies. The study was published today in the online edition of the journal Immunity. T cells, a type of white blood cell, play a major ...

Peel-and-Stick solar panels from Stanford engineering

2012-12-20

For all their promise, solar cells have frustrated scientists in one crucial regard – most are rigid. They must be deployed in stiff, often heavy, fixed panels, limiting their applications. So researchers have been trying to get photovoltaics to loosen up. The ideal: flexible, decal-like solar panels that can be peeled off like band-aids and stuck to virtually any surface, from papers to window panes. Now the ideal is real. Stanford researchers have succeeded in developing the world's first peel-and-stick thin-film solar cells. The breakthrough is described in a ...

Cellphone, GPS data suggest new strategy for alleviating traffic tie-ups

2012-12-20

Asking all commuters to cut back on rush-hour driving reduces traffic congestion somewhat, but asking specific groups of drivers to stay off the road may work even better. The conclusion comes from a new analysis by engineers from the Massachusetts Institute of Technology and the University of California, Berkeley, that was made possible by their ability to track traffic using commuters' cellphone and GPS signals. This is the first large-scale traffic study to track travel using anonymous cellphone data rather than survey data or information obtained from U.S. Census ...

Research pinpoints key gene for regenerating cells after heart attack

2012-12-20

DALLAS – Dec. 20, 2012 – UT Southwestern Medical Center researchers have pinpointed a molecular mechanism needed to unleash the heart's ability to regenerate, a critical step toward developing eventual therapies for damage suffered following a heart attack. Cardiologists and molecular biologists at UT Southwestern, teaming up to study in mice how heart tissue regenerates, found that microRNAs – tiny strands that regulate gene expression – contribute to the heart's ability to regenerate up to one week after birth. Soon thereafter the heart loses the ability to regenerate. ...

Shedding light on Anderson localization

2012-12-20

This press release is available in German. Waves do not spread in a disordered medium if there is less than one wavelength between two defects. Physicists from the universities of Zurich and Constance have now proved Nobel Prize winner Philip W. Anderson's theory directly for the first time using the diffusion of light in a cloudy medium. Light cannot spread in a straight line in a cloudy medium like milk because the many droplets of fat divert the light as defects. If the disorder – the concentration of defects – exceeds a certain level, the waves are no longer ...

Small wasps to control a big pest?

2012-12-20

With the purpose of developing new biological methods to control one of the major pests affecting the southwest Europe pine stands, a joint collaboration leaded by the Instituto Nacional de Investigação Agrária e Veterinária, Portugal (R. Petersen-Silva, P. Naves, E. Sousa), together with the Universidad de Barcelona, Spain (J. Pujade-Villar) and a member of the Museum and Institute of Zoology from the Polish Academy of Sciences, Poland, (S. Belokobylskij) initiated a research to detect the parasitoid guild of the Pine Wood Nematode (PWN) vector, Monochamus galloprovincialis ...

Sync to grow

2012-12-20

From a single-cell egg to a fully functional body: as embryos develop and grow, they must form organs that are in proportion to the overall size of the embryo. The exact mechanism underlying this fundamental characteristic, called scaling, is still unclear. However, a team of researchers from EMBL Heidelberg is now one step closer to understanding it. They have discovered that scaling of the future vertebrae in a mouse embryo is controlled by how the expression of some specific genes oscillates, in a coordinated way, between neighbouring cells. Published today in Nature, ...

Silver sheds light on superconductor secrets

2012-12-20

The first report on the chemical substitution, or doping, using silver atoms, for a new class of superconductor that was only discovered this year, is about to be published in EPJ B. Chinese scientists from Institute of Solid State Physics, Chinese Academy of Sciences, Hefei, discovered that the superconductivity is intrinsic rather than created by impurities in this material with a sandwich-style layered structure made of bismuth oxysulphide (Bi4O4S3). Superconductors with a transition temperature (TC) above the boiling temperature of liquid nitrogen (77 kelvins or −196 ...

Gene expression improves the definition of a breast cancer subtype

2012-12-20

The study conducted by the Vall d'Hebron Institute of Oncology (VHIO) in conjunction with the GEICAM cooperative group and other American and Canadian researchers has led to a change in the definition of hormone-sensitive breast tumours. Barcelona, 20 December 2012. Gene expression in breast cancer provides valuable biological information for better determining the diagnosis, treatment, risk of relapse and survival rate. However, the most common form of characterizing breast cancer is by histopathological techniques. This study, headed by Dr Aleix Prat, Head of the Translational ...

2 problems in chemical catalysis solved

2012-12-20

The research group of Professor Petri Pihko at the Department of Chemistry and the NanoScience Center of the University of Jyväskylä has solved two acute problems in chemical catalysis. The research has been funded by the Academy of Finland. In the first project, the researchers designed a novel intramolecularly assisted catalyst for the synthesis of beta amino acids. Previously published catalysts work only with aromatic side chains in the imines, but the new catalyst designed at Jyväskylä does not have this limitation. The new method might find uses in the synthesis ...

A urine test for a rare and elusive disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: